Monday 28th May, 2018
South Korean Pharma Company in Swords welcomes visit of Prime Minister Lee
SK biotek Ireland, the first South Korean contract manufacturing pharmaceutical company to invest in Ireland, were delighted to welcome His Excellency Mr. Lee Nak-yon, Prime Minister of South Korea to Swords Campus today.
His Excellency Mr. Lee Nak-yon enjoyed a tour of the manufacturing plant where SK biotek employ almost 400 scientists, chemists and engineers producing Active Pharmaceutical Ingredients for multiple Customers.
CEO of SK biotek, Dr. Junku Park said: ‘it was an honor to welcome Prime Minister Lee to Swords Campus on his visit to Ireland, the opportunity to showcase the investments of South Korea in this state-of-the-art manufacturing plant, the home to many household name therapeutics for over the last 50 years. I hope SK is just one of the first of many South Korean companies to majorly invest in Ireland; we have found Irish people to be very friendly and welcoming, the workforce to be highly educated and Ireland is a great place to do business.’
Swords Campus is the European base for SK biotek’s global marketing team. SK biotek’s ambition is to be a Top 5 contract manufacturing and development organizational for Active Pharmaceutical Ingredients by 2022.
SK is the 3rd largest conglomerate in South Korea with over 84,000 employees and $108.9bn in revenue for 2016.
The Prime Minister of South Korea visited SK biotek as part of his 3 day visit to Ireland. The visit includes a meeting with President Michael D. Higgins and talks with Taoiseach Leo Varadkar.